Bymetric
UK company intelligence
Company Active LTD

Company profile

Scancell Limited

UK company 03234881, incorporated on 7 August 1996.

HOME - Scancell

Scancell is focused on developing innovative immunotherapies for cancer that stimulate the bodys own immune system.

Company number
03234881
Incorporated
7 Aug 1996
Companies House status
Active

Company identity

Founded / incorporated
7 August 1996

Company number 03234881

Verify at Companies House
Legal name
SCANCELL LIMITED
Company type
Private Limited Company
Region
South East England
Registered address
BELLHOUSE BUILDING SANDERS ROAD
OXFORD SCIENCE PARK
OXFORD
ENGLAND
OX4 4GD
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 1
1
Company Active LTD
Scancell Limited
CRN 03234881
2
Direct and ultimate controller Active PLC
Scancell Holdings PLC
CRN 06564638

Company events

Reference milestones and recent Companies House filing stream events.

5 events
03 Aug
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jan
2027

Accounts due

Accounts Due

Next accounts due date

20 Jul
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Apr
2025

Accounts filed

Accounts

Last accounts made up date

07 Aug
1996

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2020
Funded years
2020
Age at first award
24 years

Projects

2020 Collaborative R&D Lead participant

A novel DNA vaccine that delivers long lasting immunity by stimulating high avidity CD8 T cells and strong neutralising antibodies

1 Oct 2020 to 31 Mar 2022

Awarded
£1,882,943
Total cost £2,689,918

Scancell have developed a fast, low cost and effective DNA vaccine which stimulates potent immune responses that can kill cancer cells and has already been shown to be safe and effective in the treatment of patients with skin cancer. This approach can also be used to develop a safe and effective vaccine to prevent infection with viruses such as the corona...

Product types

Collaborative R&D